Beaumont Heart and Vascular Center of Excellence
 

94-year-old Dearborn Heights woman beats cancer and heart disease

2014 was an eventful year for Lily Dudgeon of Dearborn Heights. The feisty, independent 94-year-old faced and beat the two biggest killers of humankind: first cancer, then heart disease.

It all began in late 2013 when her son found her passed out, half-in and half-out of her car in the garage. He called 911.  Lily was transported to nearby Garden City Hospital where she was diagnosed with anemia.

Read More

 

Beaumont, Royal Oak Heart & Vascular program among the best in the nation

The Heart & Vascular program at Royal Oak is ranked among the top 25 in the nation and the top hospital in Michigan, according to the 2014-15 U.S. News & World Report “Best Hospitals.”  This represents the 19th consecutive year the program has been nationally ranked. As the #1 program in Michigan, Beaumont, Royal Oak is a comprehensive, state-of-the-art facility dedicated to the prevention, diagnosis and treatment of heart problems. Beaumont’s Ernst Cardiovascular Center offers a collaborative approach to treating and managing the most complex heart and vascular conditions.

Learn more about all of Beaumont’s “Best Hospital” rankings, including naming the Royal Oak hospital as the #1 hospital in Michigan.   

 

 

In October 2013, the FDA approved the use of the MitraClip to treat patients with degenerative mitral valve regurgitation. Beaumont is the first hospital in Michigan to implant the commercially approved MitraClip to help high-risk patients with degenerative mitral valve regurgitation. Surgery is typically not an option these patients because of the severity of their condition.

“The MitraClip gives us the opportunity to help patients with severe mitral valve regurgitation that in the past did not have any options,” stated George Hanzel, M.D., Director of Cardiac Catheterization Laboratories at Beaumont, Royal Oak.

Learn More

 

1 | 2 | 3

For Patients
State of the Heart

For Physicians
Heart & Vascular Update

To help detect young people at risk for sudden cardiac arrest, Beaumont offers $25 heart checks to high school students. 

Identify Heart Disease Risks
Heart and Vascular Clinic Specialty Spotlight

Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement (TAVR) is a new option for the treatment of aortic stenosis, a common heart problem affecting approximately 1 million patients in the U.S. each year. Although surgical aortic valve replacement is the gold standard for the treatment of severe aortic stenosis, 60 percent of patients are too high-risk to undergo traditional surgery.

TAVR, an innovative minimally invasive option for these high-risk patients, was approved by the Food and Drug Administration in November 2011. In 2005, Beaumont was the first hospital in North America to perform this procedure and currently is one of only a few centers in Michigan to offer TAVR. 

To connect to a heart and vascular specialist or to schedule an appointment, call 800-633-7377.